NorthWest Biotherapeutics Inc (NWBO)

[TZOR]

That would require a great deal of explanation to compare apples to apples (CLDX to NWBO). There are slight differences and they are targeting different things (although both for GBM). My limited understanding is that CLDX has a particular group that it performs well with therefore that group is the basis of their criteria for their trials. Ours was powered for the same 6 month pfs but with the added patients we will achieve our target with only 4 pfs improvement. Many more points to compare and little time, CPA exam next week (passed regulation last month) wedding in October.

Others on the board will be able to provide a comparison of trial size before and after enlargement for both CLDX and NWBO and what that enlargement means, with context.